Rania Francis

Dr. Rania Francis

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2019 in Viruses
Verified
Journal Article
Open access
PDF file
CRClara Rolland
Clara Rolland
JAjulien Andreani
julien Andreani
ALAmina CHERIF LOUAZANI
Amina CHERIF LOUAZANI
SAsarah aherfi
sarah aherfi
RFRania Francis
Rania Francis
BSBernard LA SCOLA
Bernard LA SCOLA
The history of giant viruses began in 2003 with the identification of Acanthamoeba polyphaga mimivirus. Since then, giant viruses of amoeba enlightened an unknown part of the viral world, and every discovery and characterization of a new giant virus modifies our perception of the virosphere. This notably includes their exceptional virion sizes from 200 nm to 2 µm and their genomic complexity with length, number of genes, and functions such as translational components never seen before. Even more surprising, Mimivirus possesses a unique mobilome composed of virophages, transpovirons, and a defense system against virophages named Mimivirus virophage resistance element (MIMIVIRE). From the discovery and isolation of new giant viruses to their possible roles in humans, this review shows the active contribution of the University Hospital Institute (IHU) Mediterranee Infection to the growing knowledge of the giant viruses’ field.

19 June 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
RFRania Francis
Rania Francis
YOYusuke Ominami
Yusuke Ominami
JKJacques Bou Khalil
Jacques Bou Khalil
BSBernard LA SCOLA
Bernard LA SCOLA
The race to discover and isolate giant viruses began 15 years ago. Metagenomics is counterbalancing coculture, with the detection of giant virus genomes becoming faster as sequencing technologies develop. Since the discovery of giant viruses, many efforts have been made to improve methods for coculturing amebas and giant viruses, which remains the key engine of isolation of these microorganisms. However, these techniques still lack the proper tools for high-speed detection. In this paper, we present advances in the isolation of giant viruses. A new strategy was developed using a high-throughput microscope for real-time monitoring of cocultures using optimized algorithms targeting infected amebas. After validating the strategy, we adapted a new tabletop scanning electron microscope for high-speed identification of giant viruses directly from culture. The speed and isolation rate of this strategy has raised the coculture to almost the same level as sequencing techniques in terms of detection speed and sensitivity.

30 June 2020 in mSystems
Verified
Journal Article
Open access
PDF file
FSFrederik Schulz
Frederik Schulz
JAJulien Andreani
Julien Andreani
RFRania Francis
Rania Francis
HBHadjer Boudjemaa
Hadjer Boudjemaa
JKJacques Yaacoub Bou Khalil
Jacques Yaacoub Bou Khalil
TWTanja Woyke
Tanja Woyke
The discovery of large and giant nucleocytoplasmic large DNA viruses (NCLDV) with genomes in the megabase range and equipped with a wide variety of features typically associated with cellular organisms was one of the most unexpected, intriguing, and spectacular breakthroughs in virology. Recent studies suggest that these viruses are highly abundant in the oceans, freshwater, and soil, impact the biology and ecology of their eukaryotic hosts, and ultimately affect global nutrient cycles. Genome-resolved metagenomics is becoming an increasingly popular tool to assess the diversity and coding potential of giant viruses, but this approach is currently lacking validation.

1 January 2020 in New Microbes and New Infections
Verified
Journal Article
Open access
TTT. Takakura
T. Takakura
RFRania Francis
Rania Francis
HAH. Anani
H. Anani
MBMelhem Bilen
Melhem Bilen
Didier RaoultDidier Raoult
Didier Raoult
JKJacques Bou Khalil
Jacques Bou Khalil
Anaerosphaera massiliensis strain Marseille-P4592T (= CSURP4592T; = CCUG72452T) is a new species isolated from the stool of a 39-year-old male Pygmy from the Democratic Republic of Congo.

1 July 2019 in New Microbes and New Infections
Verified
Journal Article
Open access
RFRania Francis
Rania Francis
HAH. Anani
H. Anani
AFA. Fontanini
A. Fontanini
PFP.E. Fournier
P.E. Fournier
BSBernard LA SCOLA
Bernard LA SCOLA
JKJacques Bou Khalil
Jacques Bou Khalil
Virgibacillus ndiopensis strain Marseille-P3835T (= CSURP3835T; = CCUG70388T) is a new specie isolated from the stool of a healthy 11-year-old boy from N'Diop, Senegal.

19 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
RFRania Francis
Rania Francis
LMLE BIDEAU Marion
LE BIDEAU Marion
PJPriscilla Jardot
Priscilla Jardot
GCgrimaldier clio
grimaldier clio
Didier RaoultDidier Raoult
Didier Raoult
BSBernard LA SCOLA
Bernard LA SCOLA
SARS-CoV-2, a novel coronavirus infecting humans, is responsible for the current COVID-19 global pandemic. If several strains could be isolated worldwide, especially for in-vitro drug susceptibility testing and vaccine development, few laboratories routinely isolate SARS-CoV-2. This is due to the fact that the current co-culture strategy is highly time consuming and requires working in a biosafety level 3 laboratory. In this work, we present a new strategy based on high content screening automated microscopy (HCS) allowing large scale isolation of SARS-CoV-2 from clinical samples in 1 week. A randomized panel of 104 samples, including 72 tested positive by RT-PCR and 32 tested negative, were processed with our HCS procedure and were compared to the classical isolation procedure. Isolation rate was 43 % with both strategies on RT-PCR positive samples, and was correlated with the initial RNA viral load in the samples, where we obtained a positivity threshold of 27 Ct. Co-culture delays were shorter with HCS strategy, where 80 % of the positive samples were recovered by the third day of co-culture, as compared to only 25 % with the classic strategy. Moreover, only the HCS strategy allowed us to recover all the positive elements after 1 week of co-culture. This system allows rapid and automated screening of clinical samples with minimal operator work load, thus reducing the risks of contamination.